EMEND IV 150 MG

Country: Iżrael

Lingwa: Ingliż

Sors: Ministry of Health

Ingredjent attiv:

FOSAPREPITANT AS FOSAPREPITANT DIMEGLUMINE 150 MG

Disponibbli minn:

MERCK SHARP & DOHME ISRAEL LTD

Kodiċi ATC:

A04AD12

Għamla farmaċewtika:

POWDER FOR SOLUTION FOR INFUSION

Rotta amministrattiva:

I.V

Manifatturat minn:

MERCK SHARP & DOHME B.V, HOLLAND

Grupp terapewtiku:

APREPITANT

Indikazzjonijiet terapewtiċi:

Emend IV 150mg in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose Cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.

Data ta 'l-awtorizzazzjoni:

2011-11-01